Archived Grant Opportunity View - GO6466

The 2023 Targeted Translation Research Accelerator – Cardiovascular Disease and Diabetes Drugs and Devices Grant Opportunity is part of the MRFF and the Preventive and Public Health Research Initiative.

It will support Australian medical research and medical innovation projects that, through competitively selected national organisation/s partnering with small to medium enterprises (SMEs), accelerate into practice promising drugs and devices focused on cardiovascular disease and the complications of diabetes (types 1 and 2).

The successful independent organisation/s will be responsible for ensuring that the funding by each organisation:

• targets investment and related support through partnership projects to accelerate promising drug (topic A) or device (topic B) development projects
• promotes commercialisation of novel drugs and devices for cardiovascular disease and for complications of diabetes (types 1 and 2)
• provides a maximum of $1.5 million for each promising drug/device project
• leverages support (including co-funding) from partner organisations such as industry
• provides a minimum investment of $3 million into each of the following: cardiovascular disease; the disease-related complications in people with type 1 diabetes; and the disease-related complications in people with type 2 diabetes.

You can apply if you:

• have an Australian business number (ABN)
• are incorporated in Australia

You must also be one of the following entities:

• a medical research institute
• a university
• a corporate Commonwealth entity
• a corporation (including businesses and not for profits).

You can’t apply if you are:

• an individual
• a partnership
• an unincorporated association
• a trust (however, an incorporated trustee may apply on behalf of a trust)
• a non-corporate Commonwealth entity
• any organisation not listed in the eligible entity list
• an organisation, or your project partner is an organisation, included on the National Redress Scheme’s list of Institutions that have not joined or signified their intent to join the Scheme
• an employer of 100 or more employees that has not complied with the Workplace Gender Equality Act (2012).

We can only accept applications where you can provide:

• details of your research team, noting a maximum of 15 and that none can be named on another application submitted to a topic of this grant opportunity
• evidence from your board (or chief executive officer or equivalent if there is no board) that the project is supported, and that you can complete the project and meet the costs of the project not covered by grant funding
• letters of support from each project partner, where applicable.

We encourage joint applications provided you have a lead organisation that is the main driver of the project and is eligible to apply.

$28,500,000.00

From $13,500,000.00 to $15,000,000.00

To apply, go to: www.business.gov.au/2023-TTRA-Drugs-and-Devices

business.gov.au provides information and advice to customers via a range of channels including phone (13 28 46), email and web chat. Contact us for assistance.